Survey Finds NCI's caBIG Fails to Impress Europe's Researchers | GenomeWeb

The National Cancer Institute's Cancer Biomedical Informatics Grid Infrastructure hasn’t had much of an impact in Europe, according to a report from the European Association for Cancer Research that sought to identify caBIG's penetration in European laboratories.

EACR based its conclusions on the results from an online survey that was sent out in January to 6,396 researchers who call Europe home.

The survey was part of the Eurocancercoms project, which explores issues surrounding communication and dissemination of cancer information across Europe.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.